Oakbrook Investments LLC trimmed its holdings in Agilent Technologies Inc (NYSE:A) by 19.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 21,065 shares of the medical research company’s stock after selling 5,070 shares during the period. Oakbrook Investments LLC’s holdings in Agilent Technologies were worth $1,411,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also made changes to their positions in the company. Sumitomo Mitsui Trust Holdings Inc. increased its holdings in shares of Agilent Technologies by 9.9% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 998,225 shares of the medical research company’s stock valued at $64,086,000 after acquiring an additional 90,317 shares during the period. Timber Hill LLC purchased a new position in Agilent Technologies in the 3rd quarter valued at $1,672,000. Colony Group LLC purchased a new position in Agilent Technologies in the 2nd quarter valued at $260,000. Fisher Asset Management LLC purchased a new position in Agilent Technologies in the 3rd quarter valued at $609,000. Finally, Chevy Chase Trust Holdings Inc. grew its position in Agilent Technologies by 0.9% in the 3rd quarter. Chevy Chase Trust Holdings Inc. now owns 282,115 shares of the medical research company’s stock valued at $18,112,000 after buying an additional 2,599 shares during the last quarter.
A number of equities analysts recently weighed in on A shares. Robert W. Baird reiterated a “buy” rating and issued a $70.00 price objective on shares of Agilent Technologies in a research report on Friday, October 20th. Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price objective on the stock in a research report on Tuesday, October 10th. Deutsche Bank set a $75.00 price objective on shares of Agilent Technologies and gave the company a “buy” rating in a research report on Tuesday, November 21st. Barclays reiterated a “buy” rating and issued a $74.00 price objective on shares of Agilent Technologies in a research report on Monday, January 8th. Finally, Cowen reiterated a “hold” rating and issued a $70.00 price objective on shares of Agilent Technologies in a research report on Wednesday, November 22nd. Six research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Agilent Technologies presently has a consensus rating of “Buy” and an average price target of $69.25.
Shares of Agilent Technologies Inc (A) opened at $73.07 on Friday. The company has a market cap of $23,318.67, a price-to-earnings ratio of 34.80, a price-to-earnings-growth ratio of 2.18 and a beta of 1.28. Agilent Technologies Inc has a 1 year low of $47.05 and a 1 year high of $73.21. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30.
Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, topping the consensus estimate of $0.62 by $0.05. The company had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.17 billion. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. The business’s revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.59 EPS. sell-side analysts predict that Agilent Technologies Inc will post 2.58 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd will be given a dividend of $0.149 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a dividend yield of 0.82%. The ex-dividend date is Friday, December 29th. Agilent Technologies’s payout ratio is presently 28.57%.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.